Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report
Paediatrics
Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report
Paediatrics

Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report

Dermatol Pract Concept. 2024 Oct 30;14(4). doi: 10.5826/dpc.1404a252.

NO ABSTRACT

PMID:39652928 | DOI:10.5826/dpc.1404a252